Results

Total Results: 10 records

Showing results for "kidney disease".

  1. cds.ahrq.gov/sites/default/files/cds/artifact/18/2024_CDS_Connect_IG_Statin_CVD_Clinician_Facing.pdf
    January 01, 2024 - ESRD, ESRD encounter, dialysis procedure, and dependence on dialysis as exclusions: Chronic kidney diseaseKidney Disease: Improving Global Outcomes (KDIGO) organization (a group of nephrologists, lipid specialists … states, “People with chronic kidney disease are at higher risk of side effects from lipid medications … Lipid Management Guidelines for Adults with Chronic Kidney Disease. … AMIA Annu Symp Proc. 2016;2016:1189- 1198. 26 Kidney Disease: Improving Global Outcomes (KDIGO) Lipid
  2. cds.ahrq.gov/sites/default/files/cds/artifact/1056/2024_CDS_Connect_IG_Statin_CVD_Patient_Facing_2.pdf
    January 01, 2024 - Chronic kidney disease has been associated with an increased risk of CVD.14 However, multiple studies … states “People with chronic kidney disease are at higher risk of side effects from lipid medications … Lipid Management Guidelines for Adults with Chronic Kidney Disease. … AMIA Annu Symp Proc. 2016;2016:1189- 1198. 29 Kidney Disease: Improving Global Outcomes (KDIGO) Lipid … KDIGO Clinical Practice Guideline for Lipid Management in Chronic Kidney Disease.
  3. cds.ahrq.gov/sites/default/files/cds/artifact/1056/2023_CDS_Connect_IG_Statin_CVD_Patient_Facing.pdf
    January 01, 2023 - Chronic kidney disease has been associated with an increased risk of CVD.13 However, multiple studies … states “People with chronic kidney disease are at higher risk of side effects from lipid medications … Lipid Management Guidelines for Adults with Chronic Kidney Disease. … AMIA Annu Symp Proc. 2016;2016:1189- 1198. 30 Kidney Disease: Improving Global Outcomes (KDIGO) Lipid … KDIGO Clinical Practice Guideline for Lipid Management in Chronic Kidney Disease.
  4. cds.ahrq.gov/sites/default/files/cds/artifact/476/Pain%20Management%20Summary%20Clincial%20Decision%20Support%20Toolkit_for%20Repository_0.xlsx
    January 01, 2003 - disease, stage 1 313792 Aluminum Hydroxide 45 MG/ML / Magnesium Hydroxide 40 MG/ML Oral Suspension … N18.2 Chronic kidney disease, stage 2 (mild) 313863 Bisacodyl 5 MG Rectal Suppository … N18.3 Chronic kidney disease, stage 3 (moderate) 314087 Magnesium Hydroxide 240 MG/ML Oral Suspension … N18.4 Chronic kidney disease, stage 4 (severe) 314113 Magnesium Oxide 200 MG Oral Tablet … N18.5 Chronic kidney disease, stage 5 317055 Aluminum Hydroxide 200 MG / Magnesium Hydroxide 200 MG
  5. cds.ahrq.gov/sites/default/files/cds/artifact/1066/2023_Intervention_Content_T2DM_Part_Two_Counseling.xlsx
    January 01, 2023 - : This web-based resource goes to an NIH site, the National Institute of Diabetes and Digestive and KidneyDiseases.
  6. cds.ahrq.gov/sites/default/files/cds/artifact/1061/2024_Intervention_Content_Prediabetes_and_Type_2_Diabetes_Part_one_Screening.xlsx
    January 01, 2024 - Example Intervention Text Example Patient-Facing Intervention Text: Prediabetes and Type 2 Diabetes: Part 1, Screening General Information The example intervention text shown below is embedded in the Clinical Quality Language (CQL) files for the Prediabetes and Type 2 Diabetes Part One: Screening artifact. Imple…
  7. cds.ahrq.gov/sites/default/files/cds/artifact/1071/2023_Intervention_Content_Diet_Activity.xlsx
    January 01, 2023 - : This web-based resource goes to an NIH site, the National Institute of Diabetes and Digestive and KidneyDiseases.
  8. cds.ahrq.gov/sites/default/files/workgroups/231/apr-2017-cholesterol-wg-notes.docx
    January 01, 2017 - Cholesterol Management Work Group Meeting Summary Date 04/19/2017 Time 01:00 – 3:00 PM EST AGENDA · Welcome · Brief Overview of Existing CDS Connect Artifacts · Clarify Logic Details for USPTF-related Artifacts · Discuss Best Approach for Transforming eCQM Specifications into CDS Logic · Next Steps an…
  9. cds.ahrq.gov/sites/default/files/workgroups/34806/CDS_Connect_WG_October_2021_Summary.pdf
    January 01, 2021 - locating artifacts while working on a project at the National Institute of Diabetes and Digestive and KidneyDiseases (NIDDK).
  10. cds.ahrq.gov/sites/default/files/cds/artifact/171/Occupational%20Factors%20which%20Impact%20Diabetes,%20%20A%20Final%20Knowledge%20Resource%20Report%20(2015).pdf
    January 01, 2015 - However as disease progresses, dehydration can exacerbate kidney disease and heart disease and heat

Search the AHRQ Archive

Information and reports more than 5 years old may be found in the AHRQ Archive site.

Search Archive

Search Within A Specific AHRQ Site

You selected to view results for the following site: